Open Demat Account

Lyka Labs -LYKALABS Share Price

Sector: Pharmaceuticals

₹ 118.75

-3.45 (-2.82%)

CMPMay 03,2024 12:00 AM

Trade in Lyka Labs with IIFl Securities! Trade Now

Performance

Lyka Labs LTD KEY RATIOS

sector: Pharmaceuticals

  • CMP

    -

    -
  • Open
  • ₹ 123.75
  • Prev. Close
  • ₹ 122.20
  • Turnover(Lac.)
  • ₹ 132
  • Day's High
  • ₹ 123.75
  • Day's Low
  • ₹ 116.55
  • 52 Week's High
  • ₹ 144.30
  • 52 Week's Low
  • ₹ 88.50
  • Book Value
  • ₹ 28
  • Face Value
  • ₹ 10
  • Mkt Cap (₹ Cr.)
  • 393
  • P/E
  • 0
  • EPS
  • 0
  • Divi. Yield
  • 0

Lyka Labs LTD PEER COMPARISON

Figures of Market Capital(Mar Cap), Quaterly Net Profit(NP Qtr) and Quaterly Sales(Sales Qtr) are in ₹ Cr. View All Peer Comparison

MORE ABOUT LYKA LABS LTD

Summary

Initially manufacturing formulations, Lyka Labs brought bulk drugs into its operational fold by amalgamating Lyphin Chemicals Pvt Ltd with itself in Apr. 83. It also added a range of ayurvedic and animal health care products over the years. In 1990, it diversified into marketing medical and diagnostic equipment and instruments of Bekton Dickinson, US; Airsep Corporation, US; Coloplast, Denmark; and Terumo Corporation, Japan. Lyka Exports is the subsidiary of the company. The company offers a broad range of antibiotics used as life-savers and to treat minor infections. It has a fairly widespread product base with tropical steroids for skin disorders, anti-cancer products, cardio-vascular drugs and anti-inflammatory products. Lyka introduced, in India, cough lozenges containing dextromethorp Read More


Reports by Lyka Labs LTD


Reports by Lyka Labs LTD

x